Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing admin@sinochem-nanjing.com 3389378665@qq.com
Follow us:

2-Benzyloxy-5-Bromopyrimidine

    • Product Name 2-Benzyloxy-5-Bromopyrimidine
    • Alias 2-Benzyloxy-5-bromopyrimidine
    • Einecs 816-146-4
    • Mininmum Order 1 g
    • Factory Site Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing
    • Price Inquiry admin@sinochem-nanjing.com
    • Manufacturer Sinochem Nanjing Corporation
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    258898

    Chemical Name 2-Benzyloxy-5-Bromopyrimidine
    Molecular Formula C11H9BrN2O
    Molecular Weight 265.11
    Cas Number 1022436-11-0
    Appearance Off-white to light yellow solid
    Purity Typically ≥ 98%
    Smiles Brc1cnc(OCc2ccccc2)nc1
    Inchi InChI=1S/C11H9BrN2O/c12-10-7-13-11(14-8-10)15-6-9-4-2-1-3-5-9/h1-5,7-8H,6H2
    Storage Conditions Store at room temperature, keep container tightly closed
    Solubility Soluble in common organic solvents such as DMSO and DMF
    Synonyms 5-Bromo-2-(benzyloxy)pyrimidine

    As an accredited 2-Benzyloxy-5-Bromopyrimidine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing
    Shipping
    Storage
    Application of 2-Benzyloxy-5-Bromopyrimidine

    Applications of 2-Benzyloxy-5-Bromopyrimidine in Industrial Manufacturing

    2-Benzyloxy-5-Bromopyrimidine serves as a key intermediate in multiple advanced chemical manufacturing processes. As an experienced manufacturer, we supply this compound for critical steps where stringent quality, consistent supply, and regulatory adherence matter. Below are the main downstream applications where our product integrates into high-value industrial chains.

    1. Pharmaceutical Active Pharmaceutical Ingredient (API) Intermediate Synthesis

    In pharmaceutical manufacturing, 2-Benzyloxy-5-Bromopyrimidine acts as a core building block in synthesizing pyrimidine-based APIs, especially in oncology, anti-infective, and CNS drug programs. Major pharmaceutical companies use this material in multi-step, GMP-controlled processes. It enters the process after key halogenation and etherification steps, forming the basis for heterocyclic modifications necessary for API development. Suitability for regulated environments requires analytical traceability, genotoxic impurity controls, and strict documentation. Final synthesis routes depend on the drug target but often employ this intermediate in a condensed reaction with protected amines or nucleophilic aromatic substitution.

    Industry compliance standards

    • ICH Q7: Good Manufacturing Practice for Active Pharmaceutical Ingredients
    • 21 CFR Part 211: US cGMP requirements for finished pharmaceuticals
    • EU GMP Part II: Basic requirements for active substances used as starting materials
    • Chinese Pharmacopoeia (where local registration required)

    Typical usage ratio

    • 0.8–1.2 mole equivalents per target API intermediate; adjusted by stoichiometry and stage yield requirements

    Downstream process integration

    • Charged in initial or mid-stage condensation, cyclization, or cross-coupling reactions, with additional purification and quality testing post-coupling before final API assembly

    Final product types

    • Pyrimidine-derived APIs (anticancer drugs, antivirals, neuroactive compounds)
    • Advanced pharmaceutical intermediates for proprietary drug pipelines

    2. Crop Protection Active Ingredient Synthesis

    Manufacturers of agricultural fungicides and herbicides utilize 2-Benzyloxy-5-Bromopyrimidine in high-purity form as a precursor for pyrimidine-containing actives. Leading agrochemical companies demand batch-to-batch consistency and compliance with global pesticide registration protocols. The intermediate supports synthesis of active components through Suzuki, Buchwald–Hartwig, or other palladium-catalyzed couplings, setting a reactive site for further substitution or ring modification as specified by the active ingredient’s design. This integration is controlled by quality systems emphasizing trace contaminant removal and environmental compliance for large-scale campaigns.

    Industry compliance standards

    • ISO 9001:2015 quality system
    • OECD Guidelines for the Testing of Chemicals
    • Regulation (EC) No 1107/2009 for placing plant protection products on the EU market
    • EPA Part 180 (US tolerance regulations for pesticide residues)

    Typical usage ratio

    • 1.0 – 1.3 molar equivalents relative to the key aryl coupling partner, adjusted based on purity of starting materials and crop-protection compound design

    Downstream process integration

    • Introduced directly to cyclization or cross-coupling vessels during synthesis of agrochemical actives, usually post-initial aromatic modification steps

    Final product types

    • Pyrimidinyl triazole fungicides
    • Pyrimidine-based herbicidal actives
    • Seed treatment agents incorporating modified aromatic amines

    3. Diagnostic and Imaging Reagent Development

    2-Benzyloxy-5-Bromopyrimidine provides a critical scaffold for synthesizing radiolabeled tracers and fluorescent imaging agents used in clinical diagnostics and bioanalytical assay kits. Reagent manufacturers require ultra-pure, low-metal content intermediates to prevent background interference in analytical protocols. The compound typically undergoes metal-catalyzed substitution or radiolabeling by nucleophilic aromatic displacement, forming the foundation for bioconjugation chemistry. Tight control of residual solvents and trace impurities ensures suitability in sensitive detection environments, where end-use products must comply with regulatory norms for preclinical and clinical use.

    Industry compliance standards

    • ISO 13485:2016 (Quality management for medical devices and diagnostics)
    • USP <823> Radiopharmaceuticals
    • European Pharmacopoeia (as applicable to imaging agents and tracers)
    • FDA 21 CFR Part 820 (for medical device manufacturers)

    Typical usage ratio

    • 0.9 – 1.2 equivalents per final tracer or imaging agent molecule; ratio may be modified based on labeling efficiency and downstream purification recovery

    Downstream process integration

    • Reacted in precursor synthesis and then subjected to isotope labeling or attachment of reporter groups in the production of diagnostic kits

    Final product types

    • Radiodiagnostic tracers (PET, SPECT isotopes)
    • Fluorescent molecular probes
    • Hybrid imaging agents for biomedical research

    4. Research and Specialty Chemicals Synthesis

    Contract research organizations (CROs), custom synthesis labs, and fine chemical producers rely on this compound as a precursor for constructing libraries of functionalized pyrimidines. Researchers design new chemical entities (NCEs) or study analogs for SAR (structure–activity relationship) profiling, targeting pharmaceutical, agricultural, or material science applications. As an experienced manufacturer, we provide scalable production and custom documentation, including full impurity profiles for regulated laboratory use. The product integrates into key synthetic transformations, particularly halogen exchange, C–N and C–C coupling, and deprotection/cyclization strategies.

    Industry compliance standards

    • ISO 9001:2015 (general QC systems for specialty chemicals)
    • REACH Regulation (EC) No 1907/2006 for research chemical handling in the EU
    • GHS Safety Data Sheet (SDS) compliance

    Typical usage ratio

    • 0.95 – 1.1 equivalents per target molecule; varied according to library scale, substrate excess, and reaction efficiency requirements

    Downstream process integration

    • Employed at early-stage synthetic routes, serving as a scaffold in combinatorial synthesis via cross-coupling, nucleophilic displacement, or stepwise functionalization

    Final product types

    • Reference standards and analytical markers
    • NCE libraries for medicinal chemistry
    • Specialty pyrimidine derivatives for development in academic or industrial R&D settings
    Free Quote

    Competitive 2-Benzyloxy-5-Bromopyrimidine prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.

    We will respond to you as soon as possible.

    Tel: +8615371019725

    Email: admin@sinochem-nanjing.com

    Get Free Quote of Sinochem Nanjing Corporation

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    Introducing 2-Benzyloxy-5-Bromopyrimidine: An Honest Look at Performance, Value, and Practical Considerations

    From the Lab Bench to Real-World Synthesis

    2-Benzyloxy-5-Bromopyrimidine offers a unique balance for chemists who demand reliability in their pyrimidine scaffolds. The presence of a benzyl-protected oxy group at position two and a bromine atom at position five opens doors for selective reactions that don’t always play out with more basic building blocks. Years of organic synthesis work have shown me the frustration of using analogues prone to side reactions or inconsistent yields. This compound tends to behave predictably, especially during cross-coupling steps. In medicinal chemistry, even small hiccups in reagent purity or reactivity can derail a whole program, so having something that works well under a range of conditions is more than a small comfort—it's both a time-saver and a risk reducer.

    Specifications That Matter in Daily Work

    Typical availability comes as an off-white powder, often packed in sealed amber glass to avoid light-induced changes. Purity usually lands near the high 90s, according to most manufacturers’ HPLC readouts. While subtle, the difference between a 95% and a 99% pure product can determine whether a downstream reaction sails through or needs hours of troubleshooting. From reactivity studies, I’ve seen that minor impurities sometimes cause more problems than their low concentrations suggest. When it comes down to the actual use in Suzuki or Buchwald–Hartwig couplings, this level of clarity in the material's make-up lets you save on analytical costs and lets you trust your results.

    Plenty of other halopyrimidines don’t include the benzyloxy group, and this functional group changes the game. During deprotection or further modification, having a benzyl group opens up options compared to methoxy or other ethers. Hydrogenolysis with palladium takes the benzyl group off cleanly, giving access to free hydroxy without dragging in extra side products. In some cases, the bromine itself can act as a handle for further substitution, such as through palladium-catalyzed reactions, which are so central to assembling complex molecules. Anyone who has ever run a tough aromatic substitution knows that the right activation can make many procedures feasible, cutting out unnecessary steps and headaches.

    A Fresh Option in Medicinal Chemistry and Beyond

    Structurally, 2-Benzyloxy-5-Bromopyrimidine brings a little more to the table than simple bromo- or methoxy-pyrimidines. The benzyloxy part blocks off hydroxy reactivity early in the synthesis, then drops off conveniently when you need it gone. That’s a dose of flexibility for anyone planning multi-step syntheses. Traditional methoxy or ethoxy protections don’t always come off as cleanly—sometimes they leave behind stubborn by-products or require harsher conditions. In my experience, you can avoid acidic or basic environments that risk damaging sensitive functional groups, as a hydrogenation step for benzyl removal is milder by comparison.

    Use in pharmaceuticals stands out clearly. Thanks to the bromine at position five, you get a ready-made point of attachment for broader SAR campaigns. Medicinal chemists often look for small changes that can sweep through a batch of analogs for activity screening. The fragment-based approach relies on simple yet flexible starting materials. Here, the ability to hit either position two or five lets teams step through permutations much faster. Throughout my time supporting hit-to-lead projects, I've seen how bottlenecks often arise from a lack of robust starting points—it’s not glamorous, and rarely the focus of a paper or conference talk, but those early wins in synthetic planning open the way for faster problem-solving and idea testing.

    Comparing Alternatives: Why Choice of Scaffold Matters

    Not every pyrimidine variant brings the same potential. In direct comparison, 2-Benzyloxy-5-Bromopyrimidine outpaces simpler pyrimidines lacking halogen or protected oxy groups. Adding the bromine atom sets up entries for Suzuki–Miyaura, Sonogashira, or Buchwald–Hartwig coupling workflows, reducing the steps needed to introduce aromatic or amine substituents. Relying on unfunctionalized pyrimidines, even if they’re less expensive upfront, usually costs more in troubleshooting and extra reagents down the road. Many chemists I worked with in scaling up routes for pilot batches agree that those small differences can push a program toward—or away from—success.

    Some labs opt for methoxy-protected forms due to their price and availability, but, in practice, methoxy removal sometimes means tough conditions or hazardous waste. Benzyloxy deprotection lends itself to much gentler hydrogenation protocols, which brings peace of mind for teams concerned with operational safety as much as yield. The operational simplicity and lower environmental waste show up particularly in scale-up environments, where the difference between a process that works and one that is sustainably manageable often comes down to these fine points.

    From R&D to Process Chemistry—A Track Record of Utility

    Work in both academic and industrial settings underscores that predictable reactivity is far from a luxury in medicinal chemistry—it's practically a requirement. The reliability of 2-Benzyloxy-5-Bromopyrimidine means that reactions planned in a notebook typically reflect what comes out of the flask. During my years at the bench, being able to skip redundant purification steps or avoid contingency plans paid dividends in both morale and project timelines.

    Stability during storage matters, too. Some unprotected or lightly protected analogues will darken or degrade if left even briefly in lab conditions. I’ve opened more than one bottle of a nitro- or hydroxy-substituted halopyrimidine only to find solidification or partial oxidation. This doesn’t just mean wasted money—it can grind an entire week to a halt. In contrast, the benzyloxy group offers ample protection, and the molecule tends to remain free-flowing and stable in standard container formats for months, if not longer.

    Specifications generally include a melting point in the middle to high triple digits Celsius, though minor lot-to-lot variation is typical within these compounds. From repeated use, handling is straightforward—no need for dry boxes or special atmospheres under most scenarios. This isn’t always true for alternatives, especially those with free hydroxy or amine groups, which may hydrate or oxidize upon air exposure.

    Pushing the Edges of Application: More Than Just a Building Block

    Academic research teams discuss how the dual functional groups of 2-Benzyloxy-5-Bromopyrimidine grant access to novel heterocyclic spaces and fused ring systems. In my own collaborative projects, we found that the scaffold served well not only for core pyrimidine modification, but as a launching pad for small molecule libraries that require both retrosynthetic simplicity and post-synthetic modification options.

    Open literature shows uses in antitumor, antiviral, and CNS compound discovery projects. The bromopyrimidine nucleus comes up often in kinase inhibitor research, where researchers found that positions two and five act as great launching points for polar or bulky groups. Benzyl-protected derivatives, as opposed to triflate or silyl-protected options, survive most cross-coupling conditions so you can plan multi-step syntheses with fewer protection-deprotection cycles.

    Some researchers go so far as to build libraries with variations not just at the prototypical substitution points, but also at the benzyl group itself, exploring the effect of different aromatic substituents on target affinity or ADME properties. It’s this versatility—rooted in solid, reliable starting chemistry—that lets teams pursue avenues that might otherwise stay theoretical, especially under the constant pressure to deliver new hits and leads each month.

    Investing in Trustworthy Chemistry

    Sourcing high-quality 2-Benzyloxy-5-Bromopyrimidine saves more than money. Teams spend less time babysitting reactions or running extra purification columns because impurities settled out. Some products might cost less on paper, but losses pile up when every repeat batch delivers a surprise. Recalling several sourcing efforts for pilot-scale syntheses, skimping on quality often led to setbacks that rippled through the calendar and drove up material waste.

    The value appears each time when you compare downstream costs—operations run faster and safer, analytical teams spend less time resolving small peaks in spectra, and batch-to-batch reproducibility goes up. One senior scientist I worked with always asked whether the starting material or the purification caused delays. Over time, it became obvious that starting with right-fit pyrimidines led to smoother scale-ups and much less friction between teams.

    Responsible Use and Handling: Good Practices Come Standard

    2-Benzyloxy-5-Bromopyrimidine still requires care in handling. As with most fine chemicals, gloves, goggles, and standard chemical hoods are non-negotiable. Extended exposure to bromine-containing reagents or by-products shouldn’t be part of any workflow, since personnel safety and downstream waste treatment both count. That said, benzyloxy-protected compounds generally behave with more predictability than many other functionalized pyrimidines—fewer surprises during workups and fewer noxious by-products after reactions.

    In terms of waste, hydrogenolysis for deprotection often produces low-toxicity by-products, mostly water and toluene, rather than halogenated solvents or inorganic acids. This matches both regulatory and practical pressures in labs that want to minimize environmental impact. Drawing on past process improvements, moving to hydrogenolytic protocols generally scored better in post-campaign environmental analysis—an important consideration for organizations under scrutiny for sustainability metrics.

    Choosing 2-Benzyloxy-5-Bromopyrimidine: A Chemist’s Perspective

    Experience counts for as much as technical specification tables. In settings where innovation depends on speed, reproducibility, and the ability to trust each reagent, 2-Benzyloxy-5-Bromopyrimidine has come up consistently as a favored choice. It's a tool that doesn’t just look good in catalogs—it delivers where it matters, in the hands of chemists, project leaders, and teams meeting real deadlines. Big pharmaceutical firms and startups alike rely on consistent, well-characterized building blocks to hit milestones, and a pyrimidine derivative that offers both flexibility and reliability holds obvious appeal.

    The structure makes a difference in both design and application. Having the bromine in the five-position unlocks critical cross-coupling moves, while the benzyloxy group supports selective protection and later clean-up. This lets you build complexity only as you need, keeping syntheses nimble—a factor often more influential than the cost per gram.

    Feedback from research groups highlights that being able to avoid harsh conditions for deprotection allows more creative late-stage functionalization, supporting compound diversity in screening campaigns. Combining this with robust shelf-life and a good safety profile, it’s the rational choice for teams that recognize the broader ecosystem in which these fine chemicals play a part.

    Supporting Smarter Synthesis and Sustainable Progress

    In a world where smart choices matter at every step in the discovery chain, selecting compounds that streamline synthetic routes while lowering risks offers a competitive edge. 2-Benzyloxy-5-Bromopyrimidine stands as a testament to how design and reagent quality shape both creative science and responsible operations. For those at the bench and in leadership, picking the right pyrimidine isn’t just about the next step—it shapes the entire discovery process and plays a part in meeting both scientific and environmental goals.

    The significance here comes down to confidence: in the method, in the result, and in the team’s ability to focus on what matters most—making new discoveries, not repeating the same old troubleshooting routines. That's the unsung story behind a fine chemical that earns its place in cutting-edge labs, across discovery chemistry programs, and through scale-up to production.